TD Asset Management’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,000
| Closed | -$75K | – | 1434 |
|
|
2023
Q3 | $75K | Buy |
25,000
+12,500
| +100% | +$37.5K | ﹤0.01% | 1388 |
|
|
2023
Q2 | $30.8K | Hold |
12,500
| – | – | ﹤0.01% | 1396 |
|
|
2023
Q1 | $28.3K | Hold |
12,500
| – | – | ﹤0.01% | 1412 |
|
|
2022
Q4 | $43.6K | Hold |
12,500
| – | – | ﹤0.01% | 1421 |
|
|
2022
Q3 | $452K | Buy |
12,500
+500
| +4% | +$18.1K | ﹤0.01% | 1314 |
|
|
2022
Q2 | $228K | Buy |
12,000
+3,545
| +42% | +$67.4K | ﹤0.01% | 1374 |
|
|
2022
Q1 | $228K | Buy |
+8,455
| New | +$228K | ﹤0.01% | 1416 |
|
|
2020
Q1 | – | Sell |
-6,493
| Closed | -$253K | – | 1424 |
|
|
2019
Q4 | $253K | Buy |
+6,493
| New | +$253K | ﹤0.01% | 1340 |
|